Genes, Neurofibromatosis 2
"Genes, Neurofibromatosis 2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumor suppressor genes located on the long arm of human chromosome 22. Mutation or loss of these genes causes NEUROFIBROMATOSIS 2.
| Descriptor ID |
D016515
|
| MeSH Number(s) |
G05.360.340.024.340.375.249.345 G05.360.340.024.340.415.400.345
|
| Concept/Terms |
Genes, Neurofibromatosis 2- Genes, Neurofibromatosis 2
- Genes, nf 2
- Gene, nf 2
- nf 2 Gene
- nf 2 Genes
- nf2 Genes
- Neurofibromatosis 2 Genes
- Gene, Neurofibromatosis 2
- Neurofibromatosis 2 Gene
- Genes, nf2
- Gene, nf2
- nf2 Gene
|
Below are MeSH descriptors whose meaning is more general than "Genes, Neurofibromatosis 2".
Below are MeSH descriptors whose meaning is more specific than "Genes, Neurofibromatosis 2".
This graph shows the total number of publications written about "Genes, Neurofibromatosis 2" by people in this website by year, and whether "Genes, Neurofibromatosis 2" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Genes, Neurofibromatosis 2" by people in Profiles.
-
Menges CW, Kadariya Y, Altomare D, Talarchek J, Neumann-Domer E, Wu Y, Xiao GH, Shapiro IM, Kolev VN, Pachter JA, Klein-Szanto AJ, Testa JR. Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis. Cancer Res. 2014 Feb 15; 74(4):1261-1271.
-
Farrell CJ, Plotkin SR. Genetic causes of brain tumors: neurofibromatosis, tuberous sclerosis, von Hippel-Lindau, and other syndromes. Neurol Clin. 2007 Nov; 25(4):925-46, viii.
-
Evans JJ, Lee JH, Park YS, Jeun SS, Harwalkar JA, Safayhi H, Golubic M. Future treatment modalities for meningiomas: targeting of neurofibromatosis type 2 and Ras-regulated pathways. Neurosurg Clin N Am. 2000 Oct; 11(4):717-33.
-
Bianchi AB, Mitsunaga SI, Cheng JQ, Klein WM, Jhanwar SC, Seizinger B, Kley N, Klein-Szanto AJ, Testa JR. High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas. Proc Natl Acad Sci U S A. 1995 Nov 21; 92(24):10854-8.
-
Bianchi AB, Hara T, Ramesh V, Gao J, Klein-Szanto AJ, Morin F, Menon AG, Trofatter JA, Gusella JF, Seizinger BR, et al. Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types. Nat Genet. 1994 Feb; 6(2):185-92.